Rubius Therapeutics Inc
(RUBY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 09-2017 | 06-2017 | 12-2016 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -43,840 | -26,330 | -14,411 | 0 |
| Depreciation Amortization | 440 | 251 | 109 | 0 |
| Accounts payable and accrued liabilities | N/A | 2,017 | 788 | N/A |
| Other Working Capital | 2,730 | 3,768 | 1,133 | 0 |
| Other Operating Activity | 18,740 | 7,396 | 4,417 | 0 |
| Operating Cash Flow | $-21,930 | $-12,898 | $-7,964 | $0 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -2,250 | -1,257 | -716 | 0 |
| Investing Cash Flow | $-2,250 | $-1,257 | $-716 | $0 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | N/A | 1,500 | 1,500 | N/A |
| Common Stock Issued | N/A | 129 | 128 | N/A |
| Other Financing Activity | 121,690 | 120,106 | 120,368 | 0 |
| Financing Cash Flow | $121,690 | $121,735 | $121,996 | $0 |
| Beginning Cash Position | 7,060 | 7,068 | 7,068 | 0 |
| End Cash Position | 104,570 | 114,648 | 120,384 | 0 |
| Net Cash Flow | $97,500 | $107,580 | $113,316 | $0 |
| Free Cash Flow | ||||
| Operating Cash Flow | -21,930 | -12,898 | -7,964 | 0 |
| Capital Expenditure | N/A | -1,257 | -716 | N/A |
| Free Cash Flow | -21,930 | -14,155 | -8,680 | 0 |